BACKGROUND & OBJECTIVE AIDS and its associated gastrointestinal complications may impair the absorption of anti-tuberculosis (TB) drugs. Impaired absorption of anti-TB drugs could lead to low drug exposure, which might contribute to acquired drug resistance and reduced effectiveness of anti-TB treatment. The aim of this study was to obtain information on the status of absorption of rifampicin (...

The Series of 3-(Substitutedphenyl)-N-(4H-1,2,4-triazol-4-yl)acrylamide compounds were prepared byreaction of 4-amino-1,2,4-Triazole with Acetyl Chloride followed by Claisen-Schmidt Condensation reactionwith different aromatic aldehydes. The structures of new compounds were confirmed by IR, 1H-NMR and13C-NMR spectral data. Anti-bacterial and Anti-fungal activities were evaluated and compared wi...

Since the discoveries of a putative AIDS virus in 1984 and of millions of asymptomatic carriers in subsequent years, no general AIDS epidemic has occurred by 2011. In 2008, however, it has been proposed that between 2000 and 2005 the new AIDS virus, now called HIV, had killed 1.8 million South Africans at a steady rate of 300,000 per year and that anti-HIV drugs could have saved 330,000 of thos...

According to WHO survey in 2010 there are 34 million people who are infected with HIV and attained AIDS. Per year about 1.8 million people dies with AIDS and 2.7 million new people become infected with HIV. AIDS is a secondary immunodeficiency caused by HIV virus that belongs to retroviral family. During AIDS T-cell count in blood falls tremendously below 200 cells ìl ̄ that results to be fatal ...

Back ground: WHO data highlights that globally 36.7 million people are living with HIV. There is sparse literature on mental health research in HIV /AIDS from developing countries such as India. Aims: To study patterns of psychiatric co-morbidities and associated factors in patients of HIV/AIDS on Anti retroviral treatment. Methods: This was an analysis of patients with diagnosis of HIV/AIDS on...

The association of immune dysfunction in patients with human immunodeficiency virus (HIV) infection and AIDS and the development of autoimmune diseases is intriguing. Yet, the spectrum of reported autoimmune phenomena in these patients is increasing. An infectious trigger for immune activation is one of the postulated mechanisms and derives from molecular mimicry. During frank loss of immunocom...